Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Impactive Capital LP

2. Date of Event Requiring Statement (MM/DD/YYYY) 5/5/2020

3. Issuer Name and Ticker or Trading Symbol

AVID TECHNOLOGY, INC. [AVID]

(Last) (First) (Middle)

152 WEST 57TH STREET, 17TH FLOOR,

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___X___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

NEW YORK CITY, NY 10019

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock ⁽¹⁾	4316029	D ⁽²⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:
(1)	This Form 3 is filed jointly by Impactive Capital GP LLC ("Impactive GP"), Impactive Capital LP ("Impactive Capital"), Impactive Capital LLC ("Impactive Capital GP") and Lauren Taylor Wolfe (collectively, the Reporting Persons"), each of whom, together with Christian Asmar, is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of her or its pecuniary interest therein.
(2)	Securities of the Issuer beneficially owned by Impactive GP and Impactive Capital. As the general partner of Impactive Capital, Impactive Capital GP may be deemed to beneficially own the securities of the Issuer beneficially owned by Impactive Capital. As managing members of each of Impactive GP and Impactive Capital GP, each of Ms. Taylor Wolfe and Mr. Asmar may be deemed to beneficially own the securities of the Issuer beneficially owned by Impactive GP and Impactive Capital GP.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Impactive Capital LP 152 WEST 57TH STREET, 17TH FLOOR NEW YORK CITY, NY 10019		X
Impactive Capital GP LLC 152 WEST 57TH STREET, 17TH FLOOR NEW YORK CITY, NY 10019		X
Impactive Capital LLC 152 WEST 57TH, 17TH FLOOR NEW YORK CITY, NY 10019		X
Wolfe Lauren Taylor 152 WEST 57TH, 17TH FLOOR SUITE 1700 NEW YORK CITY, NY 10019		X

Signatures
IMPACTIVE CAPTIAL LP, By: Impactive Capital LLC, its general partner, By: /s/ Lauren Taylor Wolfe, Managing Member		5/7/2020
^**Signature of Reporting Person		Date
IMPACTIVE CAPITAL GP LLC, By: /s/ Lauren Taylor Wolfe, Managing Member		5/7/2020
^**Signature of Reporting Person		Date
IMPACTIVE CAPITAL LLC, By: /s/ Lauren Taylor Wolfe, Managing Member		5/7/2020
^**Signature of Reporting Person		Date
/s/ Lauren Taylor Wolfe		5/7/2020
^**Signature of Reporting Person		Date